Skip to content

Decoding the Cognitive Trajectory of Hong Kong SuperAgers: a Longitudinal Follow-up Study

Decoding the Cognitive Trajectory of Hong Kong SuperAgers: a Longitudinal Follow-up Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05728801
Enrollment
400
Registered
2023-02-15
Start date
2022-06-01
Completion date
2024-12-01
Last updated
2023-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related Cognitive Decline, Cognitive Deterioration, Dementia, Mild

Keywords

Cognitive maintenance, Cognitive ageing, Superagers, Cognition, Quality of life, Brain health

Brief summary

This is a prospective follow-up study conducted at the Department of Psychiatry, The Chinese University of Hong Kong. The participants, including high-performing elderly (SuperAgers), normal ageing elderly and neurocognitive disorder (NCD) patients will be re-invited from our previous cohort (2013-2014) (N=488).

Detailed description

Objectives: This study aims to investigate the cognitive changes in older adults with different cognitive statuses.

Interventions

DIAGNOSTIC_TESTAgeing

Using comprehensive cognitive tests to quality the domain-specific cognitive changes during ageing.

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to 95 Years
Healthy volunteers
Yes

Inclusion criteria

* SuperAgers are determined by the scores of global cognitive function. This ensured that the participants are divided by a measure relevant to the current study without directly biasing the results toward the domain of interest; * Normal aging: the cases with the scores of cognitive performance within 1.5 standard deviation (SD) of age and education matched normative values derived from our cohort study, of which presented with HK MoCA score greater than 26 and CDR score equal to 0; * NCD patients are defined as: evidence of modest decline in one or more cognitive domains, which is set as ≥ 1.5 SD below the age- and education-adjusted normative scores; no interference with independence in everyday activities; and no comorbid major psychiatric disorders.

Exclusion criteria

* History of bipolar disorders or psychosis; * History of major neurological deficits including stroke, transient ischemic attack or traumatic brain injury; * Comorbidities with depressive symptoms.

Design outcomes

Primary

MeasureTime frameDescription
Global cognition will be measured by the Montreal Cognitive Assessment Hong Kong version (HK MoCA)2022-2024The Montreal Cognitive Assessment Hong Kong version (HK MoCA) is a validated and widely used screening assessment for detecting cognitive impairment, which measures an array of cognitive functions such as visuospatial, memory, language and attention.HK MoCA score less than 26 indicates cognitive impairments.
Complex attention will be measured by Attention Network Test (ANT)2022-2024Attention Network Test (ANT). The ANT paradigm (Download from: https://www.sacklerinstitute.org/cornell/assays\_and\_tools/ant/jin.fan/), as a computerized test, was used and performed by E-Prime 3.0 (Psychology Software Tools, PA, USA). Within ANT paradigm, there are four types of cue: no cue, center cue, double cue, and spatial cue; and three types of flanker: neutral, congruent, and incongruent. In a given trial, a central cross-fixation point presents for 400 to 1,600 ms (randomized), subsequently is replaced for 100 ms by one of four warning cues. The target, a central arrow could appear above or below the cross-fixation and is surrounded by two flankers on each side.

Secondary

MeasureTime frameDescription
Learning and memory will be measured by Word list learning test (WLLT)2022-2024Word list learning test (WLLT) consisting of fifteen semantically non-associated words that is presented consecutively over three free trials of immediate recall (i.e., learning ability), a 20-min delayed recall (to prevent recency effects) and followed by yes/no recognition (i.e., recognition memory). Based on the proxies we developed in our previous work, components of learning and memory function will be evaluated and compared across groups, including working memory capacity (WMC), forgetting rate, delayed recall, initial learning, best learning, learning over trials (LOT) and learning ratio.

Countries

Hong Kong

Contacts

Primary ContactHanna LU, PhD
hannalu@cuhk.edu.hk85226076063
Backup ContactCandy Wong
candy.wong@cuhk.edu.hk85226076063

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026